Viatris has removed another significant legal hurdle to launching its Breyna US generic version of AstraZeneca’s Symbicort (budesonide/formoterol fumarate dihydrate) pressurized metered dose inhaler – but a potential timeline to launching what would be the country’s first generic Symbicort product remains unclear.
A US District Court for the Northern District of West Virginia judge has ruled that asserted claims of AstraZeneca’s US patent 10,166,247 are invalid both for lack of written description and lack of